The American Heart Association Owns the Science. Oura and Apple Own the Morning.

II

In This Issue II

We read the American Heart Association the way a newcomer would, from the outside, and one thing came clear before any number did. The institution still owns the science of the heart. It no longer reaches women where they read about their hearts now: the ring, the app, the lab result.

The shift is permanent

Personal control over one's own health has outlasted every campaign built around it. A woman tracks her sleep, her cycle, her blood pressure, and her blood sugar on devices she chose and pays for. The AHA's habits were set in an era when being the trusted source meant broadcasting findings outward. The audience has moved on.

What we looked at, and what we left out

We read the AHA's public face: its websites, flagship campaigns, annual reports, and the companies now competing for the same morning moment of a woman's attention. No private data. One question: what does the public picture say about the next ten years.

We read the conversation itself

We do not grade campaigns or count impressions. We read what the AHA talks about, what its competitors talk about, and the places where two important things are never said together.

Whose call this is

The decisions belong to the AHA. The next decade is already pulling in one direction, and the institution is the one positioned to answer it.

The 2050 forecast that six in ten women will have heart disease is driven by rising blood pressure and metabolic risk, the upstream territory that consumer-health companies have already claimed with language the AHA has not adopted.
Younger women's awareness fell twenty-one points in the decade to 2019, even as the Go Red for Women campaign (the AHA's flagship women's-heart effort) entered its second decade. The women it had already reached stayed loyal. The next generation never arrived, and they are the group the forecast says will be hit hardest.
The AHA's $6.1 billion research base keeps working even where the institution is absent: it is what makes a wearable's alert credible and a lab test meaningful. Today that credibility is doing its work for products the AHA did not build and earns nothing from.

— Shur Creative Partners

III

IV

V

VI

VIII

Where It Breaks VIII

Five findings, in plain language

Critical

1. The science stops at the doctor's door

The institution's authority · the woman managing her own risk

The AHA's greatest asset is its authority over the science: the research, guidelines, and standards that shape cardiovascular care. But that authority largely reaches the clinician, not the woman managing her health day to day. A 38-year-old tracking her blood pressure through an app and occasional primary-care visits is unlikely to encounter the institution behind the guidance. The science remains in the clinic; her relationship with health lives on her phone. The gap is widest among the younger women identified in the AHA's own 2050 forecast.

Where it leads → IX.1 · The relationship forms without the institution

Critical

2. The companies women check every morning carry no AHA mark

The woman's daily devices · the institution that proved the science

Oura's ring, the Apple Watch, Function Health's lab panel, and Whoop's band each measure something the AHA's research first established, and not one carries its name. These products reach a woman every day. The AHA's signature moment with women comes once a year, in February. The result is a steady stream of heart readings she trusts, delivered by brands that never had to fund the science behind them.

Where it leads → IX.2 · The science becomes a public good others monetize

Critical

3. Heart disease is explained as a diagnosis, never as a household cost

Prevention · the language of money

The AHA speaks fluently about clinical risk and rarely about cost. Yet cardiovascular care costs more than $239 billion a year, with prevention decisions increasingly made through employer health plans and household budgets. The people making those decisions think in dollars, coverage, and value. The institution with the deepest evidence in the field does not yet speak that language.

Where it leads → IX.3 · The one money relationship left in view is the wrong one

Notable

4. Admiration Is Not a Relationship

The institution people respect. The products they actually use.

The AHA helped build the science behind modern heart monitoring, yet much of its outreach still reflects a pre-wearable world. Heart health is no longer something women encounter only during a doctor's visit or an annual awareness campaign. It now arrives daily through watches, rings, apps, and lab dashboards.

Where it leads → IX.4 · Admiration without presence becomes irrelevance

Priority

5. The youngest women, most at risk, have drifted the furthest

The forecast's target group · the campaign meant to reach them

Awareness that heart disease is women's number-one killer fell fastest among the youngest women and women of color — the very groups the 2050 forecast says will be hit hardest. Go Red ran for two decades alongside that slide. It kept the women it already had, but the next generation never arrived.

Where it leads → IX.5 · They learn the upstream story from a subscription

IX

What Breaks If Nothing Changes IX

Five Signals, One Outcome

Each of these five findings points to a future. The warning signs are easy to dismiss because they do not arrive all at once. Follow them forward and the same pattern appears: the AHA keeps the credit for the science while losing the relationship with the people it exists to serve.

Finding 1 · The science stops at the doctor's door

1. The relationship forms without the institution in it

The thirty-four-year-old who has worn a ring for most of her adult life will eventually have a real scare: a flutter that will not settle, a pregnancy that turns her blood pressure dangerous. In that moment the reference she reaches for is already chosen, the device on her finger and the app it feeds, because the habit was built over a thousand ordinary mornings the institution was not part of. By the time the scare arrives, the choice of who to trust has already been made, years earlier, on days when nothing was wrong.

Finding 2 · The morning devices carry no AHA mark

2. The science becomes a public good that others monetize

The AHA's $6.1 billion research base keeps working even after the institution loses its place in daily life. It makes a wearable's alert credible, lets a lab test claim it means something, gives a prevention app its scientific footing. The institution funds that science as a public good; the products convert it into paid daily contact with the woman, taking the membership, the loyalty, the morning ritual. The AHA is left holding the most expensive credibility asset in its field while the daily value of it accrues to companies that did not pay to build it. The trap is self-reinforcing: the longer the institution stays out of daily life, the more its own research strengthens the very products standing between it and the woman.

The size of the gap is now measurable. The AHA spends $226 million a year producing the evidence that makes a heart reading mean something. Two device makers alone, Whoop at a roughly $1.1 billion annual run-rate and Oura's nearly five million paying members at close to $1 billion, already earn more than $2 billion a year selling products that evidence validates, more than the AHA's entire $1.3 billion of annual revenue. Of that daily-contact revenue, the institution captures none. A heart-health authority is underwriting a billion-dollar consumer-health business and keeping zero percent of it.

Finding 3 · Heart disease is never framed as a household cost

3. The one money relationship left in view is the wrong one

Stay out of the conversation about what heart health costs a household, and the institution's most visible money relationship with women's health stays the one that works against it. The Heart-Check seal earns the AHA certification fees from food and beverage manufacturers, and among those who have paid to put it on their products are Coca-Cola and PepsiCo. A heart-health authority collecting fees from soda and processed-food makers sits directly on the two measures where the institution is already most exposed: trust, which carries the heaviest weight in the scorecard at 35 percent, and differentiation, where the institution scores 53 out of 100, third from the bottom of the nineteen-brand field and seventeen points under the field median. The money funds the work, and the same arrangement quietly drains the credibility the work depends on.

Left in place, the conflict compounds as the certification model extends. Every new seal placed on a product that women are told to eat less of widens the gap between what the institution funds and what it appears to endorse. The British Heart Foundation holds a trust score of 74 to the AHA's 63, and a differentiation score of 66 to its 53, off a smaller financial base — proof the deficit is structural, fixable by a peer running a leaner operation. A move to license verification onto a woman's own physiological readings, rather than onto a manufacturer's product, is the version of the model that resolves the drag instead of repeating it.

Finding 4 · Admiration is not a relationship

4. Admiration without presence becomes irrelevance in slow motion

Trust that is never used in daily life thins. A woman can hold the institution in real regard and still never let it near the readings that govern her day. A decade of that and it arrives beloved and unconsulted: the logo still good for a nod of recognition, but no longer for a place in the moment she decides what to believe about her own heart. The erosion is quiet, each skipped morning adding a little, and it finishes before anyone marks the moment it began.

Finding 5 · The youngest, most-at-risk women drifted furthest

5. The upstream story gets told by someone else

The slow upstream years, long before anything goes wrong, are the ground consumer-health companies have already claimed. Function Health sells the annual blood-test panel that catches the trend early. Levels, a blood-sugar-tracking app, built its message on blood sugar as the root of heart trouble. The prescribers of the new metabolic medicines speak fluently about staying ahead of the curve. All use the active daily verb the AHA rarely does: prevent. If the institution keeps describing heart disease as an emergency to be survived, the youngest, highest-risk women will learn the language of their own upstream years from a subscription, and credit the wisdom to whichever brand delivered it daily.

Run all five forward together and they converge on one outcome: the generation that will carry the heaviest share of the disease forms its heart-health habits, and its loyalties, around products the AHA had no hand in, a decade before any of it can be undone.

X

XI

The Ranking XI

Nineteen organizations, one field of attention

This ranks health nonprofits and consumer-health companies side by side, by how strongly each holds women's heart-health attention today. It measures attention, not charitable impact: how strongly each organization holds a place in women's heart-health awareness today. SBPI is the Structural Brand Power Index, the five-measure score explained in the note below the table and in the appendix.

Rank	Organization	What they own	SBPI	Band
=1	Function Health	The annual lab-testing subscription, fronted by Dr. Mark Hyman	73.70	Strong
=1	Oura	The ring that tracks a woman's body through every life stage	73.10	Strong
=1	Apple Health	The health dashboard on a billion wrists	72.80	Strong
=4	ALS Association	The clearest single-disease cause in the field	71.20	Strong
=4	British Heart Foundation	UK heart research plus a high-street charity-shop network	70.50	Strong
6	Susan G. Komen Foundation	The pink-ribbon awareness movement	69.50	Emerging
=7	Whoop	The recovery band that added blood-test panels	68.45	Emerging
=7	American Cancer Society	The trusted cancer-screening guidelines	68.40	Emerging
=7	Levels	The message that blood sugar is the root of heart disease	68.10	Emerging
=10	Alzheimer's Association	The caregiver community and the biggest charity walk in the US	67.30	Emerging
=10	Stand Up To Cancer	The celebrity telethon that funds research teams	66.90	Emerging
12	American Diabetes Association	The diabetes standard-of-care reference	64.60	Emerging
=13	Hims & Hers Health	The telehealth service that writes the prescription too	62.90	Emerging
=13	American Heart Association	The science and trust behind cardiovascular health	62.30	Emerging
=15	World Heart Federation	World Heart Day and global heart-health policy	61.50	Emerging
=15	March of Dimes	Maternal and infant health advocacy	61.00	Emerging
=17	Garmin (Health Features)	Endurance-athlete body and heart tracking	59.80	Emerging
=17	Smart Heart Sports	Clinical-grade heart screening for young athletes	59.00	Emerging
19	F.A.S.T. Coalition	The four-letter stroke-warning checklist	55.80	Emerging

How the ranking works: the Structural Brand Power Index (SBPI) scores each organization from 0 to 100 across five weighted measures — awareness, trust, mission clarity, differentiation, and loyalty — then ranks them against the others competing for the same heart-health attention. For health causes the weighting emphasizes trust at 35 percent and mission clarity at 30 percent, then awareness at 15 percent, with differentiation and loyalty at 10 percent each. The same five measures sit behind both this ranking and the brand scorecard, so a reader can trace the AHA's position from where it stands in the field down to the single measure holding it back.

How to read the bands: 85–100 Category Dominant, 70–84 Strong, 55–69 Emerging, 40–54 Niche, below 40 Limited. The top five organizations sit in the Strong band. The American Heart Association sits at the lower edge of the Emerging band, tied for 13th of 19 — level with Hims & Hers.

On reading the gaps: these composites are structural estimates, not survey measurements. Differences smaller than roughly one point sit inside the margin and should be read as a tie, not a clean ordering — several adjacent organizations here are effectively level. An equals sign on a rank (e.g. =4) marks organizations inside that one-point band — a statistical tie. The bands above, and the single measure separating two organizations, carry more signal than any one rank number.

Function Health owns the lab subscription. Apple owns the wrist. Oura owns the woman's life stages. The American Heart Association ties for thirteenth, holding the science without yet holding a place in the daily lives where people read it.

Two different contests are stacked inside this one list. The nineteen organizations split cleanly into two groups: health nonprofits competing for the charitable dollar and the donor relationship, and consumer-health companies competing for a woman's daily attention through a ring, a watch, a lab panel, or an app. The two groups are scored on the same five measures, but they win on different ones. The product companies lead the field on differentiation by eighteen points at the midpoint (a typical product scores 79, a typical nonprofit 61) and on loyalty by fifteen (72 against 57). The nonprofits lead on mission clarity (70 against 62). On trust the two groups are level, both at 68. Which group a ranking flatters depends entirely on which measures it rewards.

As a nonprofit · tied 13th of 19

Scored the way health causes are scored, with trust and mission carrying most of the weight, the AHA comes out a credible nonprofit: eighth of the twelve nonprofits in the field, mid-pack, composite 62.30.

As a consumer competitor · rank 15 of 19

Scored the way the consumer-health field is scored, rewarding a distinctive daily presence over institutional trust, the AHA falls to fifteenth, composite 59.40, last among the seven product companies.

The AHA wins the contest it was built for and holds its own among peer charities. It is mispriced for the contest it now also has to play, where a distinctive daily presence decides the score: its gap to the product companies is six points when trust is rewarded, and triples to fifteen the moment a woman's everyday attention becomes the test.

See the full ranking in the interactive view →

XII

The Brand Scorecard XII

The whole deficit sits in one measure

62.30 / 100

Composite SBPI · Rank #13 of 19 (tied)

Band: Emerging

The foundation is intact: four of the five scores sit in the low-to-mid sixties. Differentiation is the lone outlier at 53. It measures whether the institution owns a distinctive place in a woman's daily life, where the field's leaders score 65 to 70. That one measure drags the rank down, and it carries only 10% of the total, so it is also the most fixable.

Awareness 63

Trust 63

Mission clarity 65

Differentiation 53

Loyalty 60

Trust is real, and it is not yet attached to a distinctive daily presence. That is the gap to watch: a strong score sitting right next to the weak one, with nothing yet connecting them.

The British Heart Foundation shows this gap can be closed. The UK's national heart charity ranks fifth at 70.50 on the same five measures, with higher trust, equal mission clarity, and a differentiation score of 66 against the AHA's 53, because it owns a distinctive everyday presence: roughly 700 charity shops on UK high streets and a close relationship with the National Health Service. People meet the brand in ordinary life, week in and week out, well beyond any awareness month. That settles the question a board member most needs answered. A national heart charity can hold strong trust, strong mission, and a distinctive daily presence at once. The AHA's gap is specific: that everyday presence has simply not been built yet, and a thing that has not been built can be built. The AHA has simply not shown up in daily life yet. The everyday ground is still open; no consumer device has taken it from a nonprofit that competed for it and lost.

XIII

What the AHA Can Do XIII

Five moves, ordered by what moves the score most

01 Daily Presence

Become a daily presence women use year-round

Move Go Red for Women from a February event toward a year-round companion a woman actually uses, earning a place in her ordinary Tuesday the way the ring on her finger already has one. Start with the content and tools women already search for between doctor visits, in the language of prevention and personal control.

Lifts: Differentiation, Loyalty

02 Endorsement

Charge for the cardiovascular authority every device already borrows

Every reading on the 611.5 million wearables shipped last year is only legible because of the science the AHA funded, and not one of those readings pays the AHA back. There are four ways to charge for that authority, and they climb in value. The weakest is a one-time endorsement seal on a device or a lab result, a flat badge like the Heart-Check mark the AHA already licenses to food brands in the grocery aisle. Above it sits a recurring data license, where the AHA's evidence becomes the verification standard built into the tools themselves, paid per product and scaling with the installed base. Higher still is the position that captures the most: the AHA as the neutral place where a woman's ring, her lab results, and her benefit eligibility meet and have to agree, with every device maker and lab paying to connect. Neutrality is what makes it work, and it is the one position no single device company can take. At the top, the same cardiovascular data becomes a risk feed that insurers and employers price against, sitting closest to the $239 billion a year the country spends on heart care. The AHA already runs the bottom rung in the grocery aisle and already runs a hospital registry thousands of institutions report into; the move is to climb to the custodian position, where the value is largest and the trust is hardest to copy.

Lifts: Differentiation, Trust

03 Economics

Speak the language of cost

Heart disease moves roughly $239 billion a year through the employer health plans and household budgets that decide which prevention reaches a woman first. The AHA funds the science that prices that risk, then watches insurers and benefits consultants set premiums without it. Package the cardiovascular evidence base — the projection that six in ten adults, more than 184 million, carry some form of cardiovascular disease by 2050 — as the risk-stratification inputs benefits consultants quote when they build a plan, the same way the Heart-Check seal already earns a royalty in the grocery aisle. Then certify the buyer directly: an “AHA Heart-Safe Workplace” mark an employer earns and renews, the way a building earns LEED, sitting inside the benefit decision rather than beside it.

Lifts: Mission Clarity, Differentiation

04 Women's Guide

Build the AHA's own guide for women

Stand up an evidence-grounded companion that follows a woman through pregnancy, postpartum, and menopause, the life stages where her heart risk changes and the clinical system has most often dismissed her. A breast-cancer nonprofit already ships a free phone tool that lets a woman check her own risk; the heart field has no equivalent. The AHA's research base is exactly what makes such a guide trustworthy in a way a general app cannot match.

Lifts: Mission Clarity, Differentiation, Awareness

05 Lifelong Bond

Turn the school program into a lifelong relationship

The Kids Heart Challenge reaches more than a million students and their families every year, then the relationship ends when the event does. Build a lasting connection that carries heart-health habits from the classroom into the family, so a single fundraising week grows into the start of a lifelong relationship.

Lifts: Loyalty, Mission Clarity

A second front the five moves do not reach: the AHA writes the guidelines that decide how heart disease is treated and priced, and that authority sits walled off from the community programs that touch people's lives.

06 Policy Authority

Wire the AHA's guideline authority into the drug-pricing and physician-burden fight

The AHA's deepest moat is that it authors the clinical guidelines doctors follow, the standard the federal quality agency and the physicians' association build around. That authority lives in a separate world from the school challenges, the CPR movement, and the Go Red audience, and it never enters the room where cardiovascular drug pricing and the workload crushing cardiologists get decided. The arena where the pharmaceutical lobby, the federal quality agency, and the physicians' association set the terms is exactly where guideline authorship should carry the most weight, and today the AHA brings none of its community reach to it. Connect the two: let the guidelines the AHA writes speak for the million families in the Kids Heart Challenge and the millions trained to save a life, so the authority that ends in a clinical document also shapes what a cardiovascular drug costs and whether a physician can keep practicing. Get With The Guidelines, the AHA's hospital registry already wired into thousands of institutions, is the proof this standard-setting muscle exists; the move is to point it at the pricing-and-burden fight instead of leaving it inside the clinic.

A separate front from the five score-moves: it defends the trust and authority the whole institution runs on

How the moves sequence

1 · Daily presence

Year 1, with Action 2

2 · Endorsement

Year 1, with Action 1

3 · Economics

Once daily presence carries it

4 · Women's guide

Builds on device partnerships

5 · Lifelong bond

Runs continuously throughout

Year 1Year 2Year 3

XIV

XVI

Sources & Method XVI

Appendix

A plain glossary

Structural Brand Power Index (SBPI). A single score from 0 to 100 that measures an organization across five things: how widely it is known (awareness), how much it is believed (trust), how clearly it stands for one purpose (mission clarity), whether it owns a distinctive place in daily life (differentiation), and how strongly people stay with it (loyalty). For health causes, trust and mission clarity carry the most weight.

A band. A plain-language tier the score falls into: Category Dominant (85 and up), Strong (70 to 84), Emerging (55 to 69), Niche (40 to 54), and Limited (below 40).

The field. The nineteen organizations a woman might turn to, or pass by, in a moment of attention about her own heart. It deliberately mixes health nonprofits with the consumer devices, lab tests, and apps that now compete for the same moment.

Disclosure

This brief uses only public information. No private AHA data was used: no donor records, no operating data, no campaign performance numbers. The competitive scores reflect public evidence gathered from late 2025 through early 2026.

Method note

The findings come from reading the AHA's public language alongside its competitors', and from the published Structural Brand Power Index scoring described above.

Selected public sources

American Heart Association — Annual Report and financial statements, FY2024–2025 (heart.org).
American Heart Association — "2024 Statistical Update" and Go Red for Women campaign materials (heart.org).
American Heart Association — Nation of Lifesavers and Kids Heart Challenge program pages (heart.org).
American Heart Association — 2050 cardiovascular disease prevalence projection, presidential advisory (2024).
Women's heart-disease awareness study, 2009–2019 trend data (Circulation).
British Heart Foundation — Annual Report and retail network disclosures (bhf.org.uk).
Function Health, Oura, Whoop, Levels, Apple Health, Hims & Hers — public company materials and product announcements (2025–2026).
IDC Worldwide Wearables tracker, 2025 shipments; FDA clearance notices, September 2025.
US healthcare-system trust surveys, 2020 and 2024; institutional-trust study (2025).
Global Wellness Institute — wellness-economy monitor, 2024.

Retrieval dates span late 2025 through 2 June 2026. Full URLs and per-claim citations are maintained in the research record accompanying this brief.

6 in 10	US women projected to have some form of cardiovascular disease by 2050. The rise comes mostly from climbing high blood pressure (from 48.6% of women in 2020 to 59.1% in 2050), well upstream of any heart attack.
65% → 44%	Share of women who know heart disease is their leading cause of death, fallen across 2009 to 2019. The drop was steepest among women 25 to 34 (down 81%), Hispanic women (down 86%), and Black women (down 69%).
50% / 70%	Women are 50% more likely to be given a wrong diagnosis after a heart attack, and the women who are misdiagnosed face 70% higher odds of dying within thirty days.
$6.1B	The AHA's total research funding since 1949, the largest of any organization outside the federal government.
$369.5M / $226M	The AHA now earns more from CPR training ($369.5M a year) than it spends on research ($226 million, about 18% of expenses). Total revenue is $1.36 billion.
22M / year	People trained in CPR each year by the AHA, with a goal to roughly double survival from cardiac arrest outside hospitals, from about 10% to 20% by 2030.
1M+ / 16,000	Students and schools that take part in the Kids Heart Challenge each year. The program has raised $1.8 billion for the AHA since 1978.
611.5M	Wearable devices shipped worldwide in 2025. The Apple Watch added high-blood-pressure detection, cleared by the FDA, in September 2025.
~5M / $1.1B	Oura's paid members (2026) and Whoop's yearly revenue (2025, more than double the prior year). Consumer-health companies now operate at the scale of major institutions.
$10.5M	The AHA's artificial-intelligence research grants in 2025, a small fraction of what a single consumer-health company raises in one year.

The American Heart Association Owns the Science. Oura and Apple Own the Morning.

The shift is permanent

What we looked at, and what we left out

We read the conversation itself

Whose call this is

The mandate, and its boundary

Four shifts that make the timing urgent

Prevention has overtaken treatment as the thing people buy

People now manage their own health, day to day, on their own devices

Trust in health institutions has fallen sharply, and fast

Health has become a household expense people actively manage

10 numbers that reveal AHA's reach, relevance and risk

What the public conversation is built from, and where it has holes

Five findings, in plain language

1. The science stops at the doctor's door

2. The companies women check every morning carry no AHA mark

3. Heart disease is explained as a diagnosis, never as a household cost

4. Admiration Is Not a Relationship

5. The youngest women, most at risk, have drifted the furthest

Five Signals, One Outcome

1. The relationship forms without the institution in it

2. The science becomes a public good that others monetize

3. The one money relationship left in view is the wrong one

4. Admiration without presence becomes irrelevance in slow motion

5. The upstream story gets told by someone else

Who the AHA competes with now

Nineteen organizations, one field of attention

The whole deficit sits in one measure

Five moves, ordered by what moves the score most

Become a daily presence women use year-round

Charge for the cardiovascular authority every device already borrows

Speak the language of cost

Build the AHA's own guide for women

Turn the school program into a lifelong relationship

Wire the AHA's guideline authority into the drug-pricing and physician-burden fight

How the moves sequence

A sixty-day working window

A working session with the digital team

An introduction to the device and lab companies

A handful of school sites

When the next 25-year-old woman with chest pain walks into an emergency room, what does the AHA want her to walk in carrying?

Appendix

A plain glossary

Disclosure

Method note

Selected public sources